A pilot study of tofacitinib for refractory Behçet's syndrome.
Liu J, Hou Y, Sun L, Li C, Li L, Zhao Y, Zeng X, Zhang F, Zheng W.
Liu J, et al. Among authors: zeng x.
Ann Rheum Dis. 2020 Nov;79(11):1517-1520. doi: 10.1136/annrheumdis-2020-217307. Epub 2020 May 27.
Ann Rheum Dis. 2020.
PMID: 32461206
Clinical Trial.
No abstract available.